Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.(01349.HK): Invests RMB210 million in SPD Bank structured deposits to enhance idle fund returns
Fudan Zhangjiang entered into an agreement with SPD Bank to subscribe to a structured deposit product with RMB210 million of its own idle funds generated from daily operations. The product is a principal-guaranteed floating-income type with a term of 87 days, an expected annualized return rate ranging from 0.70% to 1.90%, and is linked to the euro-to-U.S. dollar exchange rate.
On January 4, 2026, Fudan Zhangjiang (01349.HK) finalized an idle fund wealth management plan to optimize capital allocation by subscribing to structured deposits. According to the announcement, Fudan Zhangjiang signed a structured deposit product agreement with SPD Bank on the same day. The core content is to use RMB210 million of its own idle funds to subscribe to the relevant product, with the fund source being daily operational surpluses.
As stated in the announcement, the corporate structured deposit from SPD Bank subscribed this time is a principal-guaranteed floating-income product with a low risk rating. Its maturity date is March 26, 2026, and the expected annualized return rate ranges from 0.70% to 1.90%, with the specific return rate linked to the euro-to-U.S. dollar exchange rate.
Fudan Zhangjiang stated that this subscription aims to reasonably and effectively utilize idle funds, and enhance the overall capital return on the premise of ensuring capital safety and liquidity.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
Tags：
